Profile
Currently, Marion Dorsch holds the position of Chief Scientific Officer of Blueprint Medicines Corp. In her past career Dr. Dorsch was Vice President-Biology at Agios Pharmaceuticals, Inc. and Director-Cancer Biology at Sanofi-Aventis France. Dr. Dorsch received a doctorate from Freie Universität Berlin.
Marion Dorsch active positions
| Companies | Position | Start |
|---|---|---|
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | President | 2021-03-31 |
Former positions of Marion Dorsch
| Companies | Position | End |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 2021-02-28 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-10-31 |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | 2012-03-31 |
Training of Marion Dorsch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Health Technology |
- Stock Market
- Insiders
- Marion Dorsch
















